Sunday, February 20, 2011: 1:00 PM
156 (Washington Convention Center )
Building on emerging inter-governmental and corporate opportunities, Love will propose transformative changes in the way that medical R&D is conducted, including new incentive mechanisms for drug development that separate the market for the product from the market for innovation, medical innovation inducement prizes, competitive intermediaries and open source development models.
See more of: Innovative Strategies for Ensuring Access to the Benefits of Scientific Progress
See more of: Science and Society
See more of: Symposia
See more of: Science and Society
See more of: Symposia
Previous Presentation
|
Next Presentation >>